Johnson & Johnson quarterly sales rise 8.3pc, sees vaccine data "soon"


Reuters | Published: January 26, 2021 18:05:55 | Updated: January 28, 2021 10:49:01


Johnson & Johnson quarterly sales rise 8.3pc

Johnson & Johnson on Tuesday posted an 8.3 per cent rise in quarterly sales and said it would share details from its keenly watched coronavirus vaccine trial soon, as the healthcare conglomerate races to develop a potential single-dose vaccine for COVID-19.

Quarterly sales rose to $22.48 billion from $20.75 billion.

 

 

 

Share if you like